Press-release for stocks related to pharma

Prices are updated after-hours

results tags : Pharma

save search

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
ROIV | $10.37 -0.67% -0.68% 3.4M

Manufacturing

| 0.1% | O: 4.79% H: 3.02% C: -0.09%
pharma million authorization positive repurchase results study

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-29 (Crawled : 20:00) - globenewswire.com
VINC | $0.8967 -5.63% -5.97% 530K

| Email alert Add to watchlist
pharma year update financial results

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
COCP | $1.43 -1.39% 5.1K

Health Technology

| -2.01% | O: 2.68% H: 13.73% C: -8.5%
pharma antiviral financial results

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7695 0.92% 0.91% 170K

Health Technology

| 4.96% | O: 3.58% H: 0.0% C: -5.19%
GILD | News | $66.16 -1.15% -1.16% 6.4M

Health Technology

| -8.43% | O: 0.03% H: 0.16% C: -0.68%
pharma business year financial results

Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -2.56% | O: 0.3% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K

Health Technology

| -3.6% | O: -4.51% H: 4.25% C: 0.96%
pharma business year update financial results

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K

Health Technology

| -1.85% | O: 0.0% H: 24.07% C: 22.84%
pharma year update results

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
EVOK | $0.489 -10.93% -12.27% 21K

Health Technology

| -30.33% | O: -4.68% H: 5.88% C: -3.58%
pharma year financial results

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.57% | O: 0.23% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K

Health Technology

| -3.6% | O: -2.4% H: 3.69% C: 3.28%
pharma conference year financial results

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
Published: 2024-03-12 (Crawled : 12:30) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K

Health Technology

| -18.99% | O: -0.7% H: 1.75% C: 0.35%
pharma business year financial results

Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
LTRN | $5.87 -2.0% -2.04% 110K

Health Technology

| -27.57% | O: -2.06% H: 0.74% C: -21.98%
pharma report year financial results

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
Published: 2024-03-08 (Crawled : 13:00) - globenewswire.com
OCUP | $1.675 -3.74% -3.88% 240K

Health Technology

| -26.89% | O: -1.26% H: 0.0% C: -15.32%
pharma year update financial results

Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
LUMO | News | $2.64 4.76% 4.55% 12K

Health Technology

| -16.83% | O: -1.65% H: 4.03% C: 2.01%
pharma year update financial results

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
EVOK | $0.489 -10.93% -12.27% 21K

Health Technology

| -32.37% | O: 1.29% H: 2.27% C: -0.57%
pharma report year results

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
HUGE | $0.6167 1.22% 29K

Process Industries

| -27.47% | O: -13.48% H: 15.52% C: 12.05%
pharma positive sclerosis treatment research results lucid-21-302 study

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K

Health Technology

| -17.56% | O: 0.73% H: 4.08% C: 2.91%
pharma report financial results

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 07:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -4.98% | O: 3.48% H: 2.74% C: -3.58%
pharma year update financial results

NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
NAMS | $19.415 -3.17% -3.27% 220K

n/a

| -17.25% | O: -1.16% H: 4.01% C: -1.38%
pharma year update financial results

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K

Health Technology

| -20.5% | O: 0.0% H: 1.5% C: -5.0%
pharma conference year financial results

Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology